drugset / Trial / NCT00650403
Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to investigate the bioequivalence of Mylan's paroxetine hydrochloride 40 mg tablets to GSK's Paxil® 40 mg tablets following a single, oral 40 mg (1 x 40 mg) dose administered under fed conditions to healthy adult volunteers.
Timeline
- Start
- 2006-12
- Primary completion
- 2006-12
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paroxetine | Small molecule | 40 mg | Oral |
Indications
No indication recorded.